On the Use of Change in Tumor Size to Predict Survival in Clinical Oncology Studies: Toward a New Paradigm to Design and Evaluate Phase 2 Studies
Drug-independent models that link biomarker response to clinical end points are critical to support early…
Certara2009年8月1日
